ONCT-808

· Oncternal Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONCT-808, covering 2024-12-05 to 2024-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]